Baird analyst Catherine Ramsey Schulte lowered the firm’s price target on Thermo Fisher (TMO) to $553 from $573 and keeps an Outperform rating on the shares. The firm updated its model ahead of its Q2 report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- ‘Too Cheap to Ignore’: Scotiabank Says There’s an Opportunity Brewing in These 2 Large Cap Healthcare Stocks
- Thermo Fisher to acquire Sanofi steriles manufacturing site in New Jersey
- CoreWeave, Vertiv, Thermo Fisher, Altria, Bloom: Trending by Analysts
- CoreWeave initiated, Texas Instruments upgraded: Wall Street’s top analyst calls
- Scotiabank upgrades Thermo Fisher with ‘worst-case’ priced in